ArticleJournal of atherosclerosis and thrombosis2023

Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease.

Masashi Yokoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.